Hepatocellular Carcinoma Within a Noncirrhotic, Nonfibrotic, Seronegative Liver: Surgical Approaches and Outcomes

被引:45
|
作者
Young, Alastair L. [1 ]
Adair, Robert [1 ]
Prasad, K. Rajendra [1 ]
Toogood, Giles J. [1 ]
Lodge, J. Peter A. [1 ]
机构
[1] St James Univ Hosp, Hepatobiliary & Transplant Unit, Dept Hepatobiliary & Transplant Surg, Leeds LS9 7TF, W Yorkshire, England
关键词
VIRAL-HEPATITIS; RISK-FACTORS; BLOOD-LOSS; RESECTION; SURVIVAL; CANCER; TRANSPLANTATION; CLASSIFICATION; EPIDEMIOLOGY; RECURRENCE;
D O I
10.1016/j.jamcollsurg.2011.10.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Hepatocellular carcinoma (HCC) most commonly arises in patients with chronic liver disease. Data on outcomes after liver resection in patients with noncirrhotic, nonfibrotic, seronegative, referred to as a "normal" liver are limited. We aimed to investigate differences in prognostic factors and outcomes between patients presenting with HCC arising in "normal" liver (NLHCC) and that arising in "diseased" liver (DLHCC). STUDY DESIGN: All patients undergoing resection for HCC between 1994 and 2008 were assessed. Multivariable analysis of clincopathologic data from the NLHCC group was performed by comparing them with data from the group who had surgery for DLHCC during this period. RESULTS: During the 15-year study period, 142 patients underwent liver resection for HCC: 81 for NLHCC and 61 for DLHCC. NLHCCs were more often solitary but were larger and required more major resections. There was no significant difference in survival outcomes between patients who had NLHCC or DLHCC, with overall and recurrence-free 5-year survivals of 60% and 51% in NLHCC and 55% and 33% in DLHCC, respectively. In patients with NLHCC, significant factors predicting overall survival were blood transfusion requirement (p = 0.003) and age (p = 0.009), and the only significant factor at predicting recurrence-free survival was presence of multiple tumors (p = 0.025). In contrast, in DLHCC, the only significant prognostic variables were a preoperative tumor biopsy (p = 0.017) or a high neutrophil-to-lymphocyte ratio (p = 0.001), both of which predicted a poorer recurrence-free survival. CONCLUSIONS: HCC presenting in patients with a normal background liver parenchyma appears to present a different spectrum of the disease. However, excellent outcomes can be achieved after liver resection, although this often requires the use of advanced techniques due to late presentation. (J Am Coll Surg 2012;214:174-183. (C) 2012 by the American College of Surgeons)
引用
收藏
页码:174 / 183
页数:10
相关论文
共 50 条
  • [21] SURGICAL-TREATMENT OF HEPATOCELLULAR CARCINOMAS IN NONCIRRHOTIC LIVER - EXPERIENCE WITH 68 LIVER RESECTIONS
    BISMUTH, H
    CHICHE, L
    CASTAING, D
    [J]. WORLD JOURNAL OF SURGERY, 1995, 19 (01) : 35 - 41
  • [22] Recurrence after liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients
    Lanthaler, Monika
    Biebl, Matthias
    Weissenbacher, Annemarie
    Margreiter, Raimund
    Nehoda, Hermann
    [J]. CHIRURGISCHE GASTROENTEROLOGIE, 2008, 24 (01): : 51 - 54
  • [23] Hepatocellular carcinoma occurring in nonfibrotic liver:: Epidemiologic and histopathologic analysis of 80 French cases
    Bralet, MP
    Régimbeau, JM
    Pineau, P
    Dubois, S
    Loas, G
    Degos, F
    Valla, D
    Belghiti, J
    Degott, C
    Terris, B
    [J]. HEPATOLOGY, 2000, 32 (02) : 200 - 204
  • [24] Resection of hepatocellular carcinoma in noncirrhotic liver: Analysis of risk factors for survival
    Dupont-Bierre, E
    Compagnon, P
    Raoul, JL
    Fayet, G
    de Lajarte-Thirouard, AS
    Boudjema, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (05) : 663 - 670
  • [25] Innovative surgical approaches for hepatocellular carcinoma
    Riccardo Memeo
    Nicola de’Angelis
    Vito de Blasi
    Zineb Cherkaoui
    Oronzo Brunetti
    Vito Longo
    Tullio Piardi
    Daniele Sommacale
    Jacques Marescaux
    Didier Mutter
    Patrick Pessaux
    [J]. World Journal of Hepatology, 2016, 8 (13) : 591 - 596
  • [26] Innovative surgical approaches for hepatocellular carcinoma
    Memeo, Riccardo
    de'Angelis, Nicola
    de Blasi, Vito
    Cherkaoui, Zineb
    Brunetti, Oronzo
    Longo, Vito
    Piardi, Tullio
    Sommacale, Daniele
    Marescaux, Jacques
    Mutter, Didier
    Pessaux, Patrick
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (13) : 591 - 596
  • [27] INCREASED LIVER IRON STORES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA DEVELOPED ON A NONCIRRHOTIC LIVER
    TURLIN, B
    JUGUET, F
    MOIRAND, R
    LEQUILLEUC, D
    LOREAL, O
    CAMPION, JP
    LAUNOIS, B
    RAMEE, MP
    BRISSOT, P
    DEUGNIER, Y
    [J]. HEPATOLOGY, 1995, 22 (02) : 446 - 450
  • [28] Prediction of surgical outcomes of laparoscopic liver resections for hepatocellular carcinoma by defining surgical difficulty
    Periyasamy, Mohan
    Cho, Jai Young
    Ahn, Soyeon
    Han, Ho-Seong
    Yoon, Yoo-Seok
    Choi, YoungRok
    Jang, Jae Seong
    Kwon, Seong Uk
    Kim, Sungho
    Choi, Jang Kyu
    Guro, Hanisah
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12): : 5209 - 5218
  • [29] Prediction of surgical outcomes of laparoscopic liver resections for hepatocellular carcinoma by defining surgical difficulty
    Mohan Periyasamy
    Jai Young Cho
    Soyeon Ahn
    Ho-Seong Han
    Yoo-Seok Yoon
    YoungRok Choi
    Jae Seong Jang
    Seong Uk Kwon
    Sungho Kim
    Jang Kyu Choi
    Hanisah Guro
    [J]. Surgical Endoscopy, 2017, 31 : 5209 - 5218
  • [30] A MACROREGENERATIVE NODULE CONTAINING MULTIPLE FOCI OF HEPATOCELLULAR-CARCINOMA IN A NONCIRRHOTIC LIVER
    THEISE, ND
    LAPOOK, JD
    THUNG, SN
    [J]. HEPATOLOGY, 1993, 17 (06) : 993 - 996